Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

PCRX·NASDAQ

$22.32

+0.31%
HealthcareDrug Manufacturers - Specialty & Generic

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

At a Glance

Live Snapshot
Market Cap$877.96M
EPS0.1600
P/E Ratio139.50
Earnings Date08/04/2026

pcrx

Cost of Revenue

Last Annual Value

149.75M

3-Year CAGR

-9%

5-Year CAGR

5%

10-Year CAGR

8%

Pacira BioSciences, Inc.

Pacira BioSciences, Inc. Competitors Analysis of Cost of Revenue

PCRX · NASDAQ
CompanyCost of Revenue
CAGR 3Y
CAGR 5Y
CAGR 10Y
149.75M
-6.7%1.3%3.1% 
22.60M
413.4%112.5%N/A
483.89M
8.4%8.2%23.1%
ANAB logo
AnaptysBio, Inc.
NASDAQ:ANAB
2.42M
-73.6%-52.3%-16.9%
0.00
N/AN/AN/A
XNCR logo
Xencor, Inc.
NASDAQ:XNCR
10.51M
N/AN/A-14.8%
12.45M
10.0%19.3%84.0%
610.00K
N/AN/AN/A
Pacira BioSciences, Inc.

Pacira BioSciences, Inc. Fair Value Envelope

PCRX · NASDAQ

Our analysis suggests that PCRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $22.32, this represents a potential HIDDEN relative to our calculated worth for Pacira BioSciences, Inc..

Intrinsic Value
Current Price: $22.32